E. Giraldo

1.4k total citations
27 papers, 1.3k citations indexed

About

E. Giraldo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, E. Giraldo has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in E. Giraldo's work include Receptor Mechanisms and Signaling (22 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neuropeptides and Animal Physiology (8 papers). E. Giraldo is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neuropeptides and Animal Physiology (8 papers). E. Giraldo collaborates with scholars based in Italy, France and Germany. E. Giraldo's co-authors include H. Ladinsky, Eugenia Monferini, Rudolf Hammer, G.B. Schiavi, M Viganò, Antonio Giachetti, E. Montagna, R. Micheletti, Marco Turconi and Francisco Martos Crespo and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

E. Giraldo

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Giraldo Italy 18 1.0k 834 136 87 85 27 1.3k
Judith A. Poat United Kingdom 21 605 0.6× 655 0.8× 198 1.5× 120 1.4× 73 0.9× 57 1.1k
Ludo Kennis Belgium 7 537 0.5× 555 0.7× 169 1.2× 63 0.7× 102 1.2× 12 1.1k
P J Vaysse United States 9 629 0.6× 774 0.9× 123 0.9× 28 0.3× 112 1.3× 13 1.1k
Tina K. Machu United States 20 901 0.9× 847 1.0× 100 0.7× 31 0.4× 70 0.8× 40 1.3k
Robert I. Taber United States 15 623 0.6× 802 1.0× 237 1.7× 97 1.1× 95 1.1× 21 1.3k
Pamela Greengrass United Kingdom 14 444 0.4× 371 0.4× 122 0.9× 48 0.6× 76 0.9× 21 974
Sathapana Kongsamut United States 16 963 1.0× 748 0.9× 127 0.9× 272 3.1× 64 0.8× 39 1.4k
Louis L. Martin United States 15 435 0.4× 683 0.8× 161 1.2× 45 0.5× 185 2.2× 28 1.0k
Jean‐Pierre Dausse France 20 661 0.7× 464 0.6× 179 1.3× 52 0.6× 39 0.5× 32 1.0k
Richard Loiacono Australia 19 705 0.7× 571 0.7× 200 1.5× 69 0.8× 145 1.7× 33 1.1k

Countries citing papers authored by E. Giraldo

Since Specialization
Citations

This map shows the geographic impact of E. Giraldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Giraldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Giraldo more than expected).

Fields of papers citing papers by E. Giraldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Giraldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Giraldo. The network helps show where E. Giraldo may publish in the future.

Co-authorship network of co-authors of E. Giraldo

This figure shows the co-authorship network connecting the top 25 collaborators of E. Giraldo. A scholar is included among the top collaborators of E. Giraldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Giraldo. E. Giraldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Borsini, Franco, A. Brambilla, Angelo Ceci, et al.. (1998). Flibanserin < Prop INN >. Drugs of the Future. 23(1). 9–9. 11 indexed citations
3.
Borsini, Franco, E. Giraldo, Eugenia Monferini, et al.. (1995). BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(3). 52–54. 41 indexed citations
4.
Marazziti, Donatella, Silvia Marracci, Lionella Palego, et al.. (1994). Localization and gene expression of serotonin1A (5HT1A) receptors in human brain postmortem. Brain Research. 658(1-2). 55–59. 35 indexed citations
5.
Monferini, Eugenia, Paolo Gaetani, Riccardo Rodriguez y Baena, et al.. (1993). Pharmacological characterization of the 5-hydroxytryptamine receptor coupled to adenylyl cyclase stimulation in human brain. Life Sciences. 52(9). PL61–PL65. 30 indexed citations
6.
Cosentino, Ugo, Giorgio Moro, E. Giraldo, et al.. (1993). The role of electronic and conformational properties in the activity of 5-HT3 receptor antagonists. Journal of Molecular Structure THEOCHEM. 286. 275–291. 2 indexed citations
7.
Giraldo, E., et al.. (1993). Effects on general behaviour and neurotransmitter functions of a new 5-hydroxytryptamine3 receptor antagonist with potential therapeutic relevance in central nervous system disturbances.. PubMed. 43(10). 1033–41. 6 indexed citations
8.
Giraldo, E., et al.. (1992). DAU 6285: A novel antagonist at the putative 5-HT4 receptor. Life Sciences. 51(8). 583–592. 26 indexed citations
9.
Dumuis, Aline, H. Gozlan, Michèle Sebben, et al.. (1992). Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(3). 264–9. 46 indexed citations
10.
Maenhaut, Carine, J. Van Sande, C. Massart, et al.. (1991). The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. Biochemical and Biophysical Research Communications. 180(3). 1460–1468. 33 indexed citations
11.
Monferini, Eugenia, et al.. (1990). Guanylpirenzepine Distinguishes Between Neuronal m1 and m4 Muscarinic Receptor Subtypes. Journal of Receptor Research. 10(1-2). 81–96. 3 indexed citations
12.
Turconi, Marco, et al.. (1990). Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists. Journal of Medicinal Chemistry. 33(8). 2101–2108. 51 indexed citations
13.
Dammann, F., et al.. (1989). AF-DX 116 differentiates between prejunctional muscarine receptors located on noradrenergic and cholinergic nerves. Naunyn-Schmiedeberg s Archives of Pharmacology. 339(3). 268–71. 21 indexed citations
14.
Giraldo, E., et al.. (1988). Characterization of muscarinic receptor subtypes in human tissues. Life Sciences. 43(19). 1507–1515. 60 indexed citations
15.
Monferini, Eugenia, E. Giraldo, & H. Ladinsky. (1988). Characterization of the muscarinic receptor subtypes in the rat urinary bladder. European Journal of Pharmacology. 147(3). 453–458. 55 indexed citations
16.
Giraldo, E., R. Micheletti, E. Montagna, et al.. (1988). Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 1016–1020. 85 indexed citations
17.
Giraldo, E., et al.. (1988). Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.. Molecular Pharmacology. 33(6). 617–625. 68 indexed citations
18.
Crespo, Francisco Martos, et al.. (1987). Characterization of muscarinic receptors in salivary and lacrimal glands of the rat. European Journal of Pharmacology. 143(2). 189–194. 27 indexed citations
19.
Giraldo, E., Eugenia Monferini, H. Ladinsky, & Rudolf Hammer. (1987). Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116. European Journal of Pharmacology. 141(3). 475–477. 63 indexed citations
20.
Zorn, Stevin H., Ronald S. Duman, Antonio Giachetti, et al.. (1987). (R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptors.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 173–178. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith A. Poat Breakdown of academic impact, for papers by Ludo Kennis Breakdown of academic impact, for papers by P J Vaysse Breakdown of academic impact, for papers by Tina K. Machu Breakdown of academic impact, for papers by Robert I. Taber Breakdown of academic impact, for papers by Pamela Greengrass Breakdown of academic impact, for papers by Sathapana Kongsamut Breakdown of academic impact, for papers by Louis L. Martin Breakdown of academic impact, for papers by Jean‐Pierre Dausse Breakdown of academic impact, for papers by Richard Loiacono
Rankless by CCL
2026